The gut-liver axis: emerging mechanisms and therapeutic approaches for nonalcoholic fatty liver disease and type 2 diabetes mellitus
Author:
Funder
Indian Council of Medical Research
Publisher
Springer Science and Business Media LLC
Link
https://link.springer.com/content/pdf/10.1007/s00210-024-03204-6.pdf
Reference99 articles.
1. Abenavoli L, Maurizi V, Rinninella E, Tack J, Di Berardino A, Santori P, Rasetti C, Procopio AC, Boccuto L, Scarpellini E (2022) Fecal microbiota transplantation in NAFLD treatment. Medicina (Kaunas, Lithuania) 58(11):1559. https://doi.org/10.3390/medicina58111559
2. Ala M (2021) SGLT2 Inhibition for Cardiovascular Diseases, Chronic Kidney Disease, and NAFLD. Endocrinology 162(12):bqab157. https://doi.org/10.1210/endocr/bqab157
3. Alam S, Datta PK, Alam M, Hasan MJ (2024) Effect of probiotics supplementation on liver stiffness and steatosis in patients with NAFLD. Hepatology forum 5(1):18–24. https://doi.org/10.14744/hf.2022.2022.0003
4. Alkhouri N, Lawitz E, Noureddin M, DeFronzo R, Shulman GI (2020) GS-0976 (Firsocostat): an investigational liver-directed acetyl-CoA carboxylase (ACC) inhibitor for the treatment of non-alcoholic steatohepatitis (NASH). Expert Opin Investig Drugs 29(2):135–141. https://doi.org/10.1080/13543784.2020.1668374
5. Arellano-García L, Portillo MP, Martínez JA, Milton-Laskibar I (2022) Usefulness of probiotics in the management of NAFLD: evidence and involved mechanisms of action from preclinical and human models. Int J Mol Sci 23(6):3167. https://doi.org/10.3390/ijms23063167
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3